Trial Outcomes & Findings for Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi (NCT NCT03477279)

NCT ID: NCT03477279

Last Updated: 2021-06-24

Results Overview

HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1116 participants

Primary outcome timeframe

12 months

Results posted on

2021-06-24

Participant Flow

Participant milestones

Participant milestones
Measure
Individual (HIV+ Women)
HIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
These women will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Male Partners of Women in Individual
These men will have access to standard of care procedures.
Male Partners of Women in Couple
These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.
Control Population (HIV- Women)
HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.
Overall Study
STARTED
250
250
98
168
350
Overall Study
COMPLETED
203
202
98
136
349
Overall Study
NOT COMPLETED
47
48
0
32
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Individual (HIV+ Women)
n=246 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=249 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Male Partners of Women in Individual
n=98 Participants
These men will have access to standard of care procedures.
Male Partners of Women in Couple
n=167 Participants
These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.
Control Population (HIV- Women)
n=349 Participants
HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.
Total
n=1109 Participants
Total of all reporting groups
Age, Categorical
<=18 years
15 Participants
n=246 Participants
11 Participants
n=249 Participants
1 Participants
n=98 Participants
0 Participants
n=167 Participants
37 Participants
n=349 Participants
64 Participants
n=1109 Participants
Age, Categorical
Between 18 and 65 years
231 Participants
n=246 Participants
238 Participants
n=249 Participants
97 Participants
n=98 Participants
167 Participants
n=167 Participants
312 Participants
n=349 Participants
1045 Participants
n=1109 Participants
Age, Categorical
>=65 years
0 Participants
n=246 Participants
0 Participants
n=249 Participants
0 Participants
n=98 Participants
0 Participants
n=167 Participants
0 Participants
n=349 Participants
0 Participants
n=1109 Participants
Sex: Female, Male
Female
246 Participants
n=246 Participants
249 Participants
n=249 Participants
0 Participants
n=98 Participants
0 Participants
n=167 Participants
349 Participants
n=349 Participants
844 Participants
n=1109 Participants
Sex: Female, Male
Male
0 Participants
n=246 Participants
0 Participants
n=249 Participants
98 Participants
n=98 Participants
167 Participants
n=167 Participants
0 Participants
n=349 Participants
265 Participants
n=1109 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Malawi
246 Participants
n=246 Participants
249 Participants
n=249 Participants
98 Participants
n=98 Participants
167 Participants
n=167 Participants
349 Participants
n=349 Participants
1109 Participants
n=1109 Participants

PRIMARY outcome

Timeframe: 12 months

Population: This is an HIV-positive female only outcome. 134 HIV-positive women did not present for the 12 month study visit

Women who presented at 12 months and reported taking at least one dose of ART in the last seven days

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=181 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=185 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of Women Retained in Care
160 Participants
164 Participants

PRIMARY outcome

Timeframe: 12 months

Population: This is an HIV-positive female only outcome.138 HIV-positive women did not present for the 12 month study visit or did not provide the blood sample required for viral load ascertainment

Women who presented at 12 months with a viral load \<1000 copies/mL

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=178 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=184 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of Women With Viral Suppression
145 Participants
162 Participants

PRIMARY outcome

Timeframe: 12 months

Population: This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months

HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=53 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=72 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of HIV-positive Male Partners Aware of Their HIV-positive Status
44 Participants
67 Participants

PRIMARY outcome

Timeframe: 12 months

Population: This is a male only outcome. 142 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not report information on ART use

HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=52 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=72 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of HIV-positive Male Partners Retained in Care
34 Participants
59 Participants

PRIMARY outcome

Timeframe: 12 months

Population: This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not provide the blood sample required for viral load ascertainment

HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=53 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=72 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of HIV-positive Male Partners With Viral Suppression
31 Participants
53 Participants

PRIMARY outcome

Timeframe: 12 months

Population: This is a male only outcome. 162 did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-positive/indeterminate at 12 months

HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=41 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=63 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of HIV-negative Men Without HIV Exposure From Their Primary Partner
39 Participants
59 Participants

SECONDARY outcome

Timeframe: 12 months

Population: This is an HIV-positive female only outcome. For 154 observations, there was no data available on infant outcomes or no live birth

HIV-positive female participants who reported a live birth and uptake of early infant diagnosis

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=171 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=175 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis
162 Participants
158 Participants

SECONDARY outcome

Timeframe: At the day of female consent

Population: This is a female only outcome. Of the 500 HIV-positive women enrolled into the study, 44 were classified as having recently acquired HIV. Data unavailable for one HIV-negative woman.

Risk factor analysis to identify predictors of recent HIV infection among pregnant women

Outcome measures

Outcome measures
Measure
Individual (HIV+ Women)
n=44 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
Couple (HIV+ Women)
n=349 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
Predictors of Recent HIV Infection
Married to Primary Partner
38 Participants
338 Participants
Predictors of Recent HIV Infection
Not Married to Primary Partner
6 Participants
11 Participants

Adverse Events

Individual (HIV+ Women)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Couple (HIV+ Women)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Male Partners of Women in Individual

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Male Partners of Women in Couple

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Population (HIV- Women)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Nora Rosenberg, PhD, MSPH

University of North Carolina at Chapel Hill

Phone: 919-843-6580

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place